Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 14Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1

Interventions

Blood Specimen Collection 137Surveys and Questionnaires 131Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 35Drug Therapy 31Surgical Procedures, Operative 31Biopsy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Watchful Waiting 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 17Standard of Care 17Therapeutics 17Immunotherapy 16palbociclib 14trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13Hematologic Tests 12Radiosurgery 12Focus Groups 11Genetic Testing 11darolutamide 11enzalutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × radium Ra 223 dichloride × 1 year × Clear all
NCT04489719 2026-02-17

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

University of Washington

Recruiting
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT02141438 2025-10-16

REASSURE

Bayer

Completed
1,472 enrolled 18 charts
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT02803437 2025-07-10

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Bayer

Completed
334 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡